News
Students of the Institute Provençana visit IDIBELL research platforms
On Wednesday February 25th students of the Training Cycle Degree of Laboratory analysis and quality control at Provençana Institute, L’Hospitalet de Llobregat, visited the facilities of IDIBELL to know how research is done. This trimester they are studying the module of biotechnology trials and therefore they know many of the techniques used in research laboratories. […]
IDIBELL Statistical Assessment Service is back
Biostatistics and research Service operation Coordination with UICEC
New neurotransmission regulators involved in the pathogenesis of neurological diseases
Two IDIBELL research groups identify new regulators of glutamate receptors that open the door to understanding several neuronal disorders Articles reference
COMBACTE-MAGNET, an European project to promote the development of antibiotics in Europe
34 European academic partners and 5 pharmaceutical companies are launching a new project, COMBACTE-MAGNET, under the IMI AMR research programme New Drugs 4 Bad Bugs (ND4BB). ND4BB has been launched to stimulate antibiotic development in Europe. COMBACTE-MAGNET (Combating Bacterial Resistance in Europe – Molecules against Gram-Negative Infections) will bring highly innovative studies and activities related […]
Epigenetics for all audiences
María Berdasco explained as in recent decades we have gone from thinking that everything was written in our DNA, in our genome to realize that also have to consider epigenenome. “Epigenetics explains why organisms and people genetically identical as identical twins do not behave exactly the same.” Berdasco has explained that “these differences have much […]
Catalan Health Department promotes healthy habits to reduce cancer risk
Health Department has introduced the new European Code Against Cancer on the occasion of the celebration of World Cancer Day on February 4th. The forecast for 2015 is that 39,898 new cases of cancer (23,636 in men and 16,262 in women) will be diagnosed in Catalonia. It is the leading cause of death in men […]
Discovered a possible new therapeutic strategy against a very aggressive infant bone cancer
Inhibition of Sirtuin 1 is proposed as new treatment for metastatic Ewing sarcoma In Zebrafish models it reduces the proliferation or migration ability of tumor cells Ewing’s Sarcoma The mechanism Article reference